Bautista, Evella O.
HRN: 24-64-01 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/23/2026
CEFUROXIME 750MG (VIAL)
02/23/2026
03/02/2026
IV
600mg
Q8
Infectious Diarrhea
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: